Angela Sutterer

Angela Sutterer is the Chief Development Officer at Apertus Pharmaceuticals. Prior to this role, Angela has held various positions in the pharmaceutical industry, including CEO at Burke Therapeutics, Director of Technical Operations at AVADEL Pharmaceuticals, Associate Director at AMAG Pharmaceuticals, CMC Project Manager at Lumara Health, Director of Scientific Affairs at both Long Pharmaceuticals and Fleming Pharmaceuticals, and Senior Research Chemist at The Dow Chemical Company. Angela holds a Ph.D. in Organic Chemistry from Washington University in St. Louis and a BS in Chemistry from Southeast Missouri State University. Angela has extensive experience in overseeing drug and medical device life cycle management, regulatory affairs, quality control, and technical operations.